These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5536188)

  • 1. [Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
    Kanno T; Moriyama M; Kagawa M; To T; Ishimori S
    No To Shinkei; 1970 Oct; 22(10):1187-91. PubMed ID: 5536188
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
    Epstein AH; Cook JA; Goffman T; Glatstein E
    BJR Suppl; 1992; 24():209-14. PubMed ID: 1290703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
    Takakura K; Matsutani M; Koyama Y; Sing OK
    No To Shinkei; 1972 May; 24(5):585-93. PubMed ID: 4340910
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
    Sano K; Hoshino T; Nagai M
    J Neurosurg; 1968 Jun; 28(6):530-8. PubMed ID: 4233585
    [No Abstract]   [Full Text] [Related]  

  • 5. BUdR radiosensitization in anaplastic astrocytoma.
    Yung WK
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1105-6. PubMed ID: 10613300
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy of metastatic brain tumors, with special reference to continuous intracranial infusion of mitomycin C and a radiosensitizer, BUdR].
    Takakura K
    Gan No Rinsho; 1971 Apr; 17(4):263-8. PubMed ID: 5108090
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of malignant brain tumors by BAR therapy].
    Hoshino T
    No To Shinkei; 1968 Jun; 20(6):601-11. PubMed ID: 4301942
    [No Abstract]   [Full Text] [Related]  

  • 8. [Radiosensitizers for brain tumors--study of radiotherapy].
    Sano K; Hoshino T; Nagai M; Tsuchida T; Sato F
    No To Shinkei; 1967 Apr; 19(4):339-44. PubMed ID: 6072673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].
    Hoshino T
    Rinsho Hoshasen; 1968 Nov; 13(11):885-91. PubMed ID: 4304555
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical and parotid metastasis secondary to cerebral astrocytoma. Report of a case.
    Moghtader A
    Laryngoscope; 1966 Nov; 76(11):1834-41. PubMed ID: 5924330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radiotherapy of brain astrocytomas and oligodendrogliomas of the adult].
    Mazeron JJ; Simon JM; Noël G; Proudhom MA; Renard A
    Cancer Radiother; 2000 Nov; 4 Suppl 1():53s-66s. PubMed ID: 11194965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
    Phuphanich S; Levin EM; Levin VA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1769-72. PubMed ID: 6480461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of malignant brain tumours with bromouridine (thymidine analogue).
    Hoshino T; Sano K
    Acta Radiol Ther Phys Biol; 1969; 8(1-2):15-26. PubMed ID: 5800876
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemoradiation for malignant brain tumors].
    Matsutani M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2042-8. PubMed ID: 9388512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
    Hegarty TJ; Thornton AF; Diaz RF; Chandler WF; Ensminger WD; Junck L; Page MA; Gebarski SS; Hood TW; Stetson PL
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):421-8. PubMed ID: 2168357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial 5-bromodeoxyuridine and x-ray therapy.
    Bagshaw MA; Doggett RL; Smith KC; Kaplan HS; Nelsen TS
    Am J Roentgenol Radium Ther Nucl Med; 1967 Apr; 99(4):886-94. PubMed ID: 6021392
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases].
    Lokshina AM; Pelevina II
    Med Radiol (Mosk); 1973 Mar; 18(3):70-7. PubMed ID: 4267617
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and experimental results of interstitial Brachy-Curie-therapy combined with radiation sensitizing agents in infiltrative growing brain neoplasms].
    Mundinger F; Vogt P; Jobski C; Fischer HU; Ostertag C
    Strahlentherapie; 1972 Mar; 143(3):318-28. PubMed ID: 5053646
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of radiosensitizing agents in radiotherapy].
    Franke HD
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:199-201. PubMed ID: 4115508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.